Merck
HomeWebinarsRisk-based Approach to Evaluate Nitrosamines and Elemental Impurities from Single-use Components

Risk-based Approach to Evaluate Nitrosamines and Elemental Impurities from Single-use Components



WEBINAR

Residual impurities can potentially be introduced into the biopharmaceutical manufacturing process at a variety of stages. Recently, nitrosamines and elemental impurities have been a concern for regulatory agencies. These impurities originate from various raw materials, process chemicals, and manufacturing equipment. Single-use systems (SUS) incorporate a number of plastic components. A key concern related to plastic SUS is potential leachable compounds from contact materials. It’s essential to obtain information on leachables as well as nitrosamines and elemental impurities. This webinar looks into how to evaluate nitrosamine and elemental impurity risk related to SUS and filters.

In this webinar, you will:

  • Understand the potential of nitrosamine contamination
  • Learn how to leverage industry, supplier, and scientific expertise to assess the risk of elemental impurities taking advantage of ICH Q3D guidance on biologic drug manufacturing
  • See a case study using Emprove® Elemental Impurities to help you conduct an efficient elemental impurities safety evaluation D46

Speakers

Janmeet Anant, Ph.D.

Janmeet Anant, Ph.D.

Merck

Senior Regulatory Consultant

Janmeet Anant has been providing regulatory consulting for biopharmaceutical manufacturers for more than 10 years. Janmeet has a global Regulatory Affairs Certification (RAC), a B.S. in Chemistry, and a Ph.D. in Pharmacology.

Jessica Shea

Jessica Shea

Merck

Emprove® Program Manager

Jessica Shea is the Emprove® program manager responsible for filters, single-use, and chromatography resin portfolios within Merck. Previously, she was responsible for extractables and leachables global support for the BioReliance® validation services. She has more than 15 years of E&L experience, including method validation, designing of custom testing, and interpreting industry and regulatory guidance. Jessica has a B.S. in biochemistry and an MBA.

Sign In To Continue

To continue reading please sign in or create an account.

Don't Have An Account?